Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
European Journal of Radiology
|
February 15, 2025
Temporal Evolution of multiparametric magnetic resonance imaging findings following lesion-targeted focal microwave tissue coagulation for localized prostate cancer
Bunta Tokuda, Kaori Yamada, Nana Kozawa, et al.
Clinical and Translational Radiation Oncology
|
October 26, 2020
Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer - Brachytherapy enhanced late GU toxicity especially in elderly
Hideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Cancers
|
July 24, 2021
Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
Hideya Yamazaki, Gen Suzuki, Koji Masui, et al.
Scientific Reports
|
April 24, 2023
Novel device for dividing core needle biopsy specimens to provide paired mirror image-like tissues for genetic and pathological tests
Yuichi Nakamura, Keisuke Tsuji, Takumi Shiraishi, et al.
Scientific Reports
|
March 24, 2022
Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
Hideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Scientific Reports
|
March 17, 2026
Triplet versus doublet therapy in patients with metastatic hormone-sensitive prostate cancer
Keita Hayakawa, Takashi Ueda, Masahiro Iehara, et al.
Scientific Reports
|
March 18, 2021
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
Hideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 27, 2024
[Safety and Efficacy of Nivolumab plus Ipilimumab Therapy-Our Real World Experience]
Ryuichi Morita, Takeshi Ishikawa, Toshifumi Doi, et al.
Scientific Reports
|
April 5, 2024
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Hideya Yamazaki, Gen Suzuki, Koji Masui, et al.
World Journal of Urology
|
November 4, 2022
Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients
Takashi Ueda, Kazutoshi Fujita, Mitsuhisa Nishimoto, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
European Journal of Radiology
|
February 15, 2025
Temporal Evolution of multiparametric magnetic resonance imaging findings following lesion-targeted focal microwave tissue coagulation for localized prostate cancer
Bunta Tokuda, Kaori Yamada, Nana Kozawa, et al.
Clinical and Translational Radiation Oncology
|
October 26, 2020
Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer - Brachytherapy enhanced late GU toxicity especially in elderly
Hideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Cancers
|
July 24, 2021
Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
Hideya Yamazaki, Gen Suzuki, Koji Masui, et al.
Scientific Reports
|
April 24, 2023
Novel device for dividing core needle biopsy specimens to provide paired mirror image-like tissues for genetic and pathological tests
Yuichi Nakamura, Keisuke Tsuji, Takumi Shiraishi, et al.
Scientific Reports
|
March 24, 2022
Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
Hideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Scientific Reports
|
March 17, 2026
Triplet versus doublet therapy in patients with metastatic hormone-sensitive prostate cancer
Keita Hayakawa, Takashi Ueda, Masahiro Iehara, et al.
Scientific Reports
|
March 18, 2021
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
Hideya Yamazaki, Koji Masui, Gen Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 27, 2024
[Safety and Efficacy of Nivolumab plus Ipilimumab Therapy-Our Real World Experience]
Ryuichi Morita, Takeshi Ishikawa, Toshifumi Doi, et al.
Scientific Reports
|
April 5, 2024
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Hideya Yamazaki, Gen Suzuki, Koji Masui, et al.
World Journal of Urology
|
November 4, 2022
Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients
Takashi Ueda, Kazutoshi Fujita, Mitsuhisa Nishimoto, et al.
Page
of 11